<DOC>
	<DOC>NCT01738828</DOC>
	<brief_summary>The GLOBAL study is an international multi-center, prospective study designed to enroll up to 10,000 consecutive eligible subjects who are clinically referred for coronary CT angiography for assessment of suspected coronary artery disease (CAD). The purpose of the study is to perform extensive biomarker analysis of atherosclerosis in patients phenotyped using advanced imaging modalities of atherosclerosis.</brief_summary>
	<brief_title>GLOBAL Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1. Ages 1890 2. Caucasian and of NonHispanic or NonLatino origin 3. Referral for coronary CT angiography to evaluate for presence of CAD 4. The patient has signed the appropriate Institutional Review Board approved Informed Consent Form 1. Immunosuppressive or immunomodulatory therapy including any dose of systemic corticosteroids in the preceding 30 days (except if steroids are administered as premedication prior to contrast administration for CT scan within 24 hours). 2. Chemotherapy in the preceding year 3. Major surgery in the preceding 2 months 4. Blood or blood product transfusion in the preceding 2 months 5. Subjects for whom coronary CT angiography is contraindicated per institutional standard of care 6. Subjects with previous coronary arterial revascularization (PCI or CABG) 7. Subjects with atrial fibrillation/flutter or frequent irregular or rapid heart rhythms, which occurred within the past 3 months 8. Subjects with a pacemaker or implantable cardioverterdefibrillator implant 9. Active congestive heart failure or the presence of known nonischemic cardiomyopathy 10. Known genetic disorders of atherosclerosis, lipid or lipoprotein metabolism</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>